This registry highlights significant pre-hospital delays, low rates of reperfusion therapy, and high in-hospital mortality among ACS patients, particularly those with STEMI.
No takes yet. Share an insight, caveat, or question.
Registry data informs Indian ACS epidemiology and care planning; leaves open need for outcome-focused prospective studies.
Negi et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: